Skip to main content
 

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published Jan. 21, 2010 in the online journal PLoS ONE.

Systemic pre-exposure administration of antiretroviral drugs provides protection against intravenous and rectal transmission of HIV in mice with human immune systems, according to a new study published Jan. 21, 2010 in the online journal PLoS ONE.

“These results provide evidence that a universal approach to prevent all forms of HIV transmission in all settings might be possible,” said J. Victor Garcia-Martinez, Ph.D., professor in the department of medicine at the University of North Carolina at Chapel Hill School of Medicine and senior author of the study.  “This could greatly facilitate the implementation of a single program capable of targeting virtually all groups of people at high risk of HIV infection.” For full release

 

Comments are closed.